U.S. brand and generic prescription drug revenue 2005-2016
Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
Source
More information
Statistics on "Generics and biosimilars"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- Number of ANDA approvals in U.S. 2015-2017, by type
- U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- Medicaid program savings through generic drug usage by U.S. state 2015
- Average number of approved ANDAs per month in U.S. 2009-2017
- Number of pharmaceuticals on China's national reimbursement drug list
- Generic drug cost change for Canada 2016-2018
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Share of drug dispensing costs in select public drug plans Canada 2011-2017
- Value of expiring patents in U.S. 2016-2019
- Impact of cannabis use on faculty impairment according to the French 2016
- Italy: prevalence of generic sartan medication use 2010-2016
- Market share of the generic pharmaceuticals in Norway 2000-2017
- Value share of generic pharmaceuticals market in Portugal 2000-2017
- Leading hair growth products in U.S. 2018
Statistics on "Generics and biosimilars"
Related topics
About Statista
